Gene · 5698
Papers4,120
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
741 to 760 of 4,120
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Targeting Lysine-Specific Demethylase 1 Rescues Major Histocompatibility Complex Class I Antigen Presentation and Overcomes Programmed Death-Ligand 1 Blockade Resistance in SCLC. | J Thorac Oncol | 2022 | 35691495 | PubTator, text mining | PubMed |
| Alpha-smooth muscle actin-positive cancer-associated fibroblasts secreting osteopontin promote growth of luminal breast cancer. | Cell Mol Biol Lett | 2022 | 35690734 | PubTator, text mining | PubMed |
| Genome-wide transcriptome profiling of human trabecular meshwork cells treated with TGF-β2. | Sci Rep | 2022 | 35689009 | PubTator, text mining | PubMed |
| Age, education, and political involvement differences in daily election-related stress. | Curr Psychol | 2022 | 35669213 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing reveals immunological rewiring at the maternal-fetal interface following asymptomatic/mild SARS-CoV-2 infection. | Cell Rep | 2022 | 35662411 | PubTator, text mining | PubMed |
| Inherited TNFSF9 deficiency causes broad Epstein-Barr virus infection with EBV+ smooth muscle tumors. | J Exp Med | 2022 | 35657354 | PubTator, text mining | PubMed |
| A Novel Classification and Scoring Method Based on Immune-Related Transcription Factor Regulation Patterns in Gastric Cancer. | Front Oncol | 2022 | 35656510 | PubTator, text mining | PubMed |
| Transcriptomic datasets of cancer patients treated with immune-checkpoint inhibitors: a systematic review. | J Transl Med | 2022 | 35641998 | PubTator, text mining | PubMed |
| Incidence of HPVs, EBV, and MMTV-Like Virus in Breast Cancer in Qatar. | Intervirology | 2022 | 35640537 | PubTator, text mining | PubMed |
| Machine Learning for the Identification of a Common Signature for Anti-SSA/Ro 60 Antibody Expression Across Autoimmune Diseases. | Arthritis Rheumatol | 2022 | 35635731 | PubTator, text mining | PubMed |
| Immunosuppressive Tumor Microenvironment and Immunotherapy of Epstein-Barr Virus-Associated Malignancies. | Viruses | 2022 | 35632758 | PubTator, text mining | PubMed |
| Comparative Proteomic Analysis Reveals Mx1 Inhibits Senecavirus A Replication in PK-15 Cells by Interacting with the Capsid Proteins VP1, VP2 and VP3. | Viruses | 2022 | 35632606 | PubTator, text mining | PubMed |
| Extranodal Natural Killer/T-Cell Lymphomas: Current Approaches and Future Directions. | J Clin Med | 2022 | 35628826 | PubTator, text mining | PubMed |
| miR-18a Mediates Immune Evasion in ER-Positive Breast Cancer through Wnt Signaling. | Cells | 2022 | 35626709 | PubTator, text mining | PubMed |
| The Human Ntn-Hydrolase Superfamily: Structure, Functions and Perspectives. | Cells | 2022 | 35626629 | PubTator, text mining | PubMed |
| Biology of the Extracellular Proteasome. | Biomolecules | 2022 | 35625547 | PubTator, text mining | PubMed |
| A Decentralized Kidney Transplant Biopsy Classifier for Transplant Rejection Developed Using Genes of the Banff-Human Organ Transplant Panel. | Front Immunol | 2022 | 35619722 | PubTator, text mining | PubMed |
| Mechanism of effective combination radio-immunotherapy against 9464D-GD2, an immunologically cold murine neuroblastoma. | J Immunother Cancer | 2022 | 35618290 | PubTator, text mining | PubMed |
| DNA damage promotes HLA class I presentation by stimulating a pioneer round of translation-associated antigen production. | Mol Cell | 2022 | 35594857 | PubTator, text mining | PubMed |
| Anisi Stellati Fructus, a Significant Traditional Chinese Medicine (TCM) Herb and Its Bioactivity against Gastric Cancer. | Evid Based Complement Alternat Med | 2022 | 35586683 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5698/papers?page=38